Cleared Traditional

K213424 - Jabra Enhance Plus (FDA 510(k) Clearance)

Jan 2022
Decision
90d
Days
Class 2
Risk

K213424 is an FDA 510(k) clearance for the Jabra Enhance Plus. This device is classified as a Self-fitting Air-conduction Hearing Aid, Prescription (Class II - Special Controls, product code QDD).

Submitted by GN Hearing A/S (Ballerup, DK). The FDA issued a Cleared decision on January 19, 2022, 90 days after receiving the submission on October 21, 2021.

This device falls under the Ear, Nose, Throat FDA review panel. Regulated under 21 CFR 874.3325. A Self-fitting Air-conduction Hearing Aid Is A Wearable Sound Amplifying Device That Is Intended To Compensate For Impaired Hearing And Incorporates Technology, Including Software, That Allows Users To Program Their Hearing Aids. This Technology Integrates User Input With A Self-fitting Strategy And Enables Users To Independently Derive And Customize Their Hearing Aid Fitting And Settings. This Is A Prescription Hearing Aid..

Submission Details

510(k) Number K213424 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 21, 2021
Decision Date January 19, 2022
Days to Decision 90 days
Submission Type Traditional
Review Panel Ear, Nose, Throat (EN)
Summary Summary PDF

Device Classification

Product Code QDD - Self-fitting Air-conduction Hearing Aid, Prescription
Device Class Class II - Special Controls
CFR Regulation 21 CFR 874.3325
Definition A Self-fitting Air-conduction Hearing Aid Is A Wearable Sound Amplifying Device That Is Intended To Compensate For Impaired Hearing And Incorporates Technology, Including Software, That Allows Users To Program Their Hearing Aids. This Technology Integrates User Input With A Self-fitting Strategy And Enables Users To Independently Derive And Customize Their Hearing Aid Fitting And Settings. This Is A Prescription Hearing Aid.